Cameroon vs Niger: Antiretroviral therapy coverage for PMTCT
Cameroon
59.0%
in 2024
Niger
63.0%
in 2024
Cameroon rank
62nd
Niger rank
60th
Antiretroviral therapy coverage for PMTCT over time
- Cameroon
- Niger
How they compare
Niger currently reports 63.0% against 59.0% in Cameroon, a difference of 4.0%.
That makes Niger's figure about 1.1 times Cameroon's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Niger ahead.
Cameroon ranks 62nd and Niger ranks 60th of 84 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.7% | 4.7% | 10.0% | Cameroon |
| 2010s | 79.6% | 56.3% | 23.3% | Cameroon |
| 2020s | 74.0% | 42.6% | 31.4% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cameroon or Niger?
- Niger, at 63.0% against 59.0% in Cameroon as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cameroon and Niger?
- 4.0%, with Niger ahead.
- How many years of comparable data are there for Cameroon and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Niger rank globally for antiretroviral therapy coverage for pmtct?
- Cameroon ranks 62nd and Niger ranks 60th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).